International Journal of Artiﬁcial Intelligence for Science AI for Medical Application Review

AI for Medical Application: Current

Trends, Challenges, and Future

Directions

Wei Wang

1,∗

Huaibei New Age Science and Trade Co.

Corresponding author: Wei Wang.

E-mail: wei

wang@163.com.

https://doi.org/10.63619/ijais.v1i1.003

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Published by the

International Journal of Artiﬁcial Intelligence for Science (IJAI4S).

Manuscript received January 9, 2025; revised February 28, 2025. published March 17, 2025.

Abstract: The integration of Artiﬁcial Intelligence (AI) into healthcare has signiﬁcantly enhanced diagnostic

precision, treatment strategies, pharmaceutical advancements, and hospital management. This review examines

the role of AI in medical imaging, drug discovery, robotic surgery, epidemiology, and clinical decision-making.

Techniques such as deep learning and natural language processing (NLP) have exhibited exceptional proﬁ-

ciency in interpreting medical images, forecasting disease trajectories, and optimizing healthcare infrastructure.

Furthermore, the incorporation of AI into electronic health records (EHRs) and wearable health monitoring

technologies has strengthened patient management and facilitated early disease identiﬁcation. Despite these

technological strides, several challenges remain, including concerns about data security, interpretability of AI

models, biases in algorithms, and ethical dilemmas. Adherence to regulations such as HIPAA and GDPR is

essential to maintaining patient data conﬁdentiality. Additionally, efforts to improve AI fairness and transparency

are crucial in fostering conﬁdence among medical practitioners and p atients. Future developments in medical AI

are anticipated to be driven by advancements in multimodal AI, federated learning, and generative AI. Rather

than displacing human expertise, AI will act as a complementary tool, equipping healthcare professionals

with data-driven insights to reﬁne clinical decision-making. Ensuring sustainable AI deployment and fostering

international collaboration will be pivotal in making AI-driven medical solutions accessible and equitable. This

paper provides an extensive review of AI’s present applications, challenges, and future potential in medicine,

highlighting its contributions to precision healthcare and improved patient outcomes.

Keywords: Medical AI, Healthcare Technology, Medical Imaging, Drug Discovery, AI in Surgery, Public

Health, Explainable AI, Personalized Medicine

1. Introduction

Artiﬁcial Intelligence (AI) has become a pivotal technology in healthcare, signiﬁcantly reshaping patient

management, diagnostic procedures, and therapeutic planning. Utilizing extensive datasets, AI models

recognize trends and generate predictions, improving both clinical judgments and workﬂow efﬁciency [1].

The expanding role of AI in medicine is fueled by innovations in machine learning, deep learning, and

natural language processing, facilitating the automated interpretation of intricate medical information, such

as imaging data, genomic sequences, and electronic health records.

AI has been widely adopted in medical imaging and diagnostics, with deep learning models enhancing

disease detection and classiﬁcation accuracy across radiology, pathology, and dermatology [2]. In drug

discovery, AI expedites the identiﬁcation of promising drug candidates by predicting molecular interactions

and reﬁning drug formulations, signiﬁcantly cutting development time and costs compared to traditional

methods [3]. Personalized medicine also beneﬁts from AI-driven analysis of patient-speciﬁc data, including

genetic proﬁles and clinical history, to recommend customized treatment strategies, improving therapeutic

Vol. 01, No. 01, March 2025 Page 23

International Journal of Artiﬁcial Intelligence for Science AI for Medical Application Review

outcomes while minimizing side effects [4]. Furthermore, AI plays a crucial role in healthcare management

by optimizing hospital workﬂows, forecasting patient admissions, and automating administrative processes,

leading to greater efﬁciency and cost reduction [5].

Despite these advancements, AI implementation in medicine encounters challenges such as data privacy

risks, ethical dilemmas, and the necessity for regulatory frameworks to ensure safety and reliability.

Its integration into clinical settings demands rigorous validation and improved model interpretability to

establish trust among healthcare providers and patients. This review examines the current landscape of AI

applications in medicine, addresses key obstacles in its deployment, and explores prospective advancements

in AI-driven healthcare innovations.

2. AI in Medical Imaging and Diagnostics

Artiﬁcial Intelligence (AI), particularly deep learning, has revolutionized medical imaging and diagnostics.

Convolutional neural networks (CNNs) have been extensively employed across imaging techniques such

as computed tomography (CT), magnetic resonance imaging (MRI), X-rays, and ultrasound. These models

demonstrate exceptional performance in image classiﬁcation, anomaly detection, organ segmentation, and

disease progression assessment, thereby enhancing diagnostic precision and efﬁciency [6].

Computer-aided diagnosis (CAD) systems have been developed to support radiologists by improving

image interpretation, minimizing diagnostic errors, and reducing workload. AI-driven systems have proven

particularly effective in early disease detection, especially in oncology, cardiology, and neurology [7]. In

pathology, deep learning algorithms process digitized histopathological slides to detect malignant tissues

with high accuracy. Automated histopathological analysis has shown remarkable effectiveness in identifying

cancers such as breast and prostate cancer, sometimes surpassing human pathologists in diagnostic accuracy

[8].

The fusion of multi-modal data, integrating imaging, genetic, and clinical information, has further reﬁned

patient diagnostics and treatment planning. AI models trained on diverse datasets facilitate personalized

medicine by offering comprehensive assessments of disease states and predicting individual patient prog-

noses [9]. For instance, AI-driven analysis of MRI scans and genomic data has successfully classiﬁed

glioblastoma subtypes, crucial for tailoring patient-speciﬁc treatments.

Recently, transformer architectures, initially developed for natural language processing, have been adapted

for medical imaging tasks. These models excel in segmentation, classiﬁcation, detection, and clinical report

generation by capturing long-range dependencies and contextual information within medical images [10].

Vision Transformers (ViTs), in particular, have demonstrated superior performance in radiology, often

surpassing conventional CNNs in speciﬁc imaging applications, underscoring their potential for advancing

medical diagnostics.

Despite these breakthroughs, AI-driven medical imaging still faces hurdles, including concerns about

data privacy, the necessity for large annotated datasets, and ensuring model generalizability across varied

populations. Future research should emphasize enhancing AI interpretability, reﬁning federated learning

for privacy-preserving data sharing, and establishing standardized evaluation metrics to facilitate broader

clinical adoption.

3. AI in Drug Discovery and Personalized Medicine

Artiﬁcial Intelligence (AI) has signiﬁcantly transformed drug discovery and personalized medicine by

improving protein structure prediction, facilitating molecular design, and enabling individualized treatment

strategies.

3.1. AI in Drug Discovery

3.1.1. Protein Structure Prediction and Molecular Design

Understanding protein structures is fundamental to drug development, yet conventional experimental tech-

niques are often labor-intensive and costly. AI has revolutionized this domain, with models like AlphaFold

by DeepMind demonstrating exceptional accuracy in predicting three-dimensional protein conﬁgurations

from amino acid sequences [11]. This advancement accelerates drug target identiﬁcation and the design

Vol. 01, No. 01, March 2025 Page 24

International Journal of Artiﬁcial Intelligence for Science AI for Medical Application Review

of therapeutic compounds.

Beyond structural insights, AI-driven generative models, such as variational autoencoders and generative

adversarial networks, contribute to the rapid design of novel drug candidates with optimized properties,

streamlining the development pipeline [12].

3.1.2. Computational Pharmacology and AI-Enhanced Drug Screening

AI supports computational pharmacology by modeling drug-target interactions, evaluating potential adverse

effects, and optimizing lead compounds. By leveraging extensive chemical and biological datasets, machine

learning algorithms can pinpoint promising drug candidates, reducing reliance on traditional in vitro and

in vivo screening processes [13].

3.2. AI in Personalized Medicine

3.2.1. Genomic Analysis and Precision Healthcare

In the realm of personalized medicine, AI examines genomic data to detect genetic variations linked

to speciﬁc diseases, enabling the formulation of targeted therapies. Integrating genetic information with

clinical records allows AI to support precision medicine initiatives, ensuring treatments are tailored to

individual patient proﬁles, enhancing efﬁcacy, and mitigating adverse reactions [14].

3.2.2. AI-Guided Treatment Optimization

AI systems assist clinicians by generating evidence-based treatment recommendations. By analyzing patient

history, genetic markers, and lifestyle data, AI predicts individual therapeutic responses and suggests

optimal treatment plans, contributing to improved healthcare outcomes [15].

3.3. Recent Developments

Recent progress includes the emergence of AlphaFold3, which extends beyond structure prediction to

model protein-ligand interactions, further advancing drug discovery methodologies [16]. Additionally, AI-

generated personalized therapy regimens, leveraging genetic and clinical data, are being deployed to offer

tailored treatments, improving patient-speciﬁc medical interventions [17].

4. AI in Medical Robotics and Surgery

The incorporation of Artiﬁcial Intelligence (AI) into medical robotics and surgical interventions has

substantially improved surgical accuracy, efﬁciency, and patient outcomes. This section examines ad-

vancements in AI-powered robotic surgery, computer vision applications in surgical navigation, AI-assisted

minimally invasive and remote procedures, and emerging trends such as autonomous r obotic surgeries.

4.1. AI-Enhanced Robotic Surgery Systems

AI has played a crucial role in evolving robotic-assisted surgery, extending capabilities beyond traditional

manual techniques. The da Vinci Surgical System exempliﬁes this progress, leveraging AI to enhance

dexterity and precision in minimally invasive operations [18]. AI algorithms facilitate automation in various

surgical tasks, including suturing and knot tying, thereby alleviating cognitive demands on surgeons and

reducing the likelihood of human errors [19].

4.2. Computer Vision for Surgical Navigation

Computer vision, an essential AI component, enables real-time image-guided navigation during surgeries.

By accurately tracking surgical instruments and recognizing anatomical structures, these systems support

intraoperative decision-making [ 20]. Vision-based tracking presents an efﬁcient alternative to conventional

external tracking mechanisms, fostering a more intuitive and precise surgical workﬂow [21].

4.3. AI-Assisted Minimally Invasive and Remote Procedures

AI has signiﬁcantly advanced minimally invasive surgeries (MIS) and remote surgical capabilities. In MIS,

AI supports tasks such as instrument segmentation and tissue differentiation, leading to smaller incisions

Vol. 01, No. 01, March 2025 Page 25

International Journal of Artiﬁcial Intelligence for Science AI for Medical Application Review

and faster patient recovery [22]. In telesurgery, AI-driven robotic platforms allow specialists to conduct

remote procedures, extending specialized surgical expertise to underserved areas [23].

4.4. Future Prospects: AI-Enabled Autonomous Surgeries

The development of AI-powered autonomous surgical systems represents a key area of future innovation.

These systems aim to independently execute speciﬁc surgical procedures under human supervision. Re-

search in imitation learning, where robots are trained through surgical video demonstrations, suggests that

AI-assisted systems may achieve competency levels comparable to human surgeons [24]. Such advance-

ments could lead to standardized surgical techniques and improved patient outcomes.

4.5. Recent Advances

Recent innovations in AI and medical robotics include the integration of augmented reality (AR) to enhance

surgical accuracy. Companies such as Medivis employ AR and computer vision to provide real-time, three-

dimensional visualizations of patient anatomy during operations [25]. Additionally, AI-driven analytics are

being used to assess surgical performance, contributing to improved training methodologies and patient

safety [26].

5. AI in Healthcare Management and Clinical Decision Support

Artiﬁcial Intelligence (AI) has revolutionized healthcare management and clinical decision support systems

(CDSS), increasing efﬁciency, accuracy, and personalized care.

5.1. Healthcare Resource Optimization and Administrative Automation

AI-driven solutions optimize healthcare resources, streamline patient management, and enhance hospital

operations. By analyzing extensive datasets, AI predicts patient admissions, reﬁnes staff allocation, and

manages inventory, leading to cost reductions and improved service delivery. AI-powered automation

also alleviates administrative burdens, including medical documentation and scheduling, thereby reducing

physician workload [27].

5.2. Natural Language Processing in Electronic Health Records

Natural Language Processing (NLP), a subset of AI, enables the extraction of meaningful insights from

unstructured data in Electronic Health Records (EHRs). NLP-based algorithms detect patient symptoms,

track medical histories, and assess treatment responses, facilitating disease diagnosis, treatment planning,

and clinical research. However, challenges remain, including privacy concerns, inconsistencies in data

quality, and the need for large annotated datasets [28].

5.3. Predictive Analytics for Disease Risk Assessment

AI-driven predictive modeling allows for early detection of high-risk patients by analyzing demographic

information, medical records, and lifestyle factors. These models enable proactive intervention strategies for

chronic conditions such as cardiovascular diseases and diabetes, thus improving patient care and treatment

outcomes [29].

5.4. AI-Powered Medical Assistants and Dialogue Systems

AI-driven medical dialogue systems, including ChatGPT, function as intelligent health assistants by offering

patients medical information, addressing health-related queries, and aiding clinicians in decision-making.

Utilizing advanced NLP techniques, these systems generate human-like responses, improving patient

engagement and accessibility to healthcare services [30].

5.5. Recent Innovations

Recent advancements include AI-driven agents designed to assist with clinical trial enrollment, post-

hospitalization patient care, and physician brieﬁngs. These AI applications aim to alleviate physician

burnout by handling administrative responsibilities, allowing healthcare professionals to dedicate more

time to direct patient care [31].

Vol. 01, No. 01, March 2025 Page 26

International Journal of Artiﬁcial Intelligence for Science AI for Medical Application Review

6. AI in Epidemiology and Public Health

Artiﬁcial Intelligence (AI) has emerged as a crucial asset in epidemiology and public health, enabling

sophisticated approaches to disease forecasting, outbreak detection, policy development, and remote health

surveillance.

6.1. Infectious Disease Prediction and Epidemic Monitoring

AI’s capability to analyze extensive datasets has signiﬁcantly improved the prediction and monitoring

of infectious disease outbreaks. Machine learning models process real-time patient data, environmental

variables, and epidemiological patterns to forecast disease spread and identify vulnerable regions. The

Canadian AI system BlueDot, for instance, employs natural language processing and machine learning

techniques to synthesize diverse data sources, effectively anticipating the dissemination of infectious

diseases [32]. During the COVID-19 pandemic, AI models played a pivotal role in outbreak prediction

and disease progression tracking, facilitating timely public health interventions [25].

6.2. AI in Public Health Policy Development

AI aids policymakers by analyzing complex health data, revealing trends in disease transmission, and

informing the development of targeted public health strategies. These models evaluate intervention efﬁcacy,

optimize healthcare resource distribution, and enhance the overall responsiveness of public health initiatives

[23]. By integrating AI-driven insights, decision-makers can improve epidemic control measures and design

proactive policies to mitigate future health crises.

6.3. Wearable Technology and Remote Health Surveillance

The fusion of AI with wearable technology has revolutionized remote health monitoring, enabling contin-

uous assessment of physiological metrics such as heart rate, physical activity, and biochemical markers.

AI algorithms detect anomalies in these datasets, facilitating early diagnosis and personalized medical

interventions. Studies indicate that AI-powered wearable devices can reliably capture and analyze health

signals, offering new prospects for preemptive disease detection and real-time therapeutic responses [ 33].

Additionally, AI-driven remote monitoring platforms have been deployed to track vital signs and predict

disease trajectories, improving patient outcomes while alleviating strain on healthcare systems [34].

7. Challenges and Ethical Considerations

The implementation of Artiﬁcial Intelligence (AI) in healthcare introduces several challenges and ethical

concerns that must be addressed to ensure safe, effective, and equitable medical applications.

7.1. Data Privacy and Security

AI-driven healthcare solutions depend on vast amounts of patient data, necessitating stri ct adherence to

privacy and security regulations. Legal frameworks such as HIPAA in the U.S. and GDPR in the EU outline

protocols for protecting medical records, restricting unauthorized access, and fortifying cybersecurity to

prevent data breaches [35].

7.2. Explainability and Trust in AI

The opacity of AI models, particularly deep learning systems, creates a ”black box” issue, where the

reasoning behind predictions remains unclear. In medical contexts, this lack of transparency can reduce

trust and hinder adoption by healthcare professionals and patients. Enhancing AI interpretability is essential

to ensure clinical decisions remain comprehensible and justiﬁable [36].

7.3. Bias and Equity in AI

AI models trained on non-representative datasets risk perpetuating biases, potentially leading to disparities

in healthcare outcomes among different demographic groups. Mitigating these biases requires diverse and

inclusive training data, continuous auditing, and algorithmic adjustments to ensure fairness and equitable

treatment across populations [21].

Vol. 01, No. 01, March 2025 Page 27

International Journal of Artiﬁcial Intelligence for Science AI for Medical Application Review

7.4. Regulatory and Ethical Complexities

The integration of AI in healthcare raises critical legal and ethical issues, including accountability, in-

formed consent, and unintended consequences. Developing comprehensive regulatory policies and ethical

guidelines is crucial to governing AI deployment responsibly and ensuring its alignment with medical

standards and patient rights [22].

8. Challenges and Ethical Considerations

The adoption of Artiﬁcial Intelligence (AI) in healthcare presents various challenges and ethical concerns

that must be addressed to ensure safe, effective, and equitable implementation.

8.1. Data Privacy and Security

AI-driven healthcare systems handle vast amounts of sensitive patient information, necessitating strict

adherence to privacy and security regulations. Policies s uch as HIPAA in the U.S. and GDPR in the EU

outline protocols for protecting medical data, controlling access, and enhancing cybersecurity to mitigate

risks associated with data breaches [35]. As AI applications continue to expand, ensuring compliance with

these legal frameworks remains a fundamental requirement for maintaining patient conﬁdentiality and trust

[33].

8.2. Explainability and Trust in AI

The complexity of AI models, particularly deep learning architectures, often results in a lack of trans-

parency, commonly referred to as the ”black box” issue. In healthcare, the inability to interpret AI-driven

decisions can reduce trust and hinder acceptance among medical professionals and patients. Enhancing

AI interpretability is crucial for ensuring that clinical decisions remain transparent, comprehensible, and

justiﬁable [32].

8.3. Bias and Fairness

AI models trained on non-representative datasets risk perpetuating biases, leading to disparities in healthcare

outcomes across different demographic groups. Addressing these biases requires diverse and inclusive

training data, rigorous auditing processes, and algorithmic reﬁnements to ensure fairness and equitable

healthcare delivery [36].

8.4. Regulatory and Ethical Considerations

The deployment of AI in healthcare raises complex legal and ethical concerns, including questions of

accountability, informed consent, and potential unintended consequences. Developing robust regulatory

frameworks and ethical guidelines is essential to ensure AI adoption aligns with medical standards and

upholds patient rights [32]. Establishing clear accountability structures for AI-driven clinical decisions is

crucial for fostering responsible and transparent AI implementation in medicine.

9. Future Directions and Conclusion

The integration of Artiﬁcial Intelligence (AI) in healthcare has driven signiﬁcant advancements, with its

future trajectory poised to introduce even more transformative changes. This section examines anticipated

developments, the collaborative relationship between AI and medical professionals, the importance of

sustainable AI deployment, and the need for global cooperation.

9.1. Emerging Trends in Medical AI

9.1.1. Multimodal AI

Next-generation AI systems will integrate diverse medical data sources—such as imaging, genomics,

electronic health records, and real-time physiological monitoring—to generate comprehensive insights

into patient health. This multimodal approach aims to enhance diagnostic accuracy and facilitate more

personalized treatment strategies by incorporating a holistic view of patient information [37].

Vol. 01, No. 01, March 2025 Page 28

International Journal of Artiﬁcial Intelligence for Science AI for Medical Application Review

9.1.2. Federated Learning

Federated learning enables AI models to be trained on decentralized datasets while maintaining local

data privacy. In healthcare, this technique allows institutions to collaboratively develop AI models without

compromising patient conﬁdentiality, leading to more robust and generalizable AI applications across

medical settings [23].

9.1.3. Generative AI

Generative AI, including models such as ChatGPT, has the potential to reshape medical education, pa-

tient engagement, and clinical decision support by synthesizing vast medical literature and generating

contextually relevant text. These AI systems can assist in medical documentation, provide patient-friendly

explanations, and summarize clinical guidelines, contributing to enhanced healthcare service delivery [33].

9.2. Collaboration Between AI and Healthcare Professionals

AI is designed to augment rather than replace healthcare practitioners. By automating administrative

tasks and offering data-driven insights, AI enhances clinical workﬂows, allowing medical professionals to

devote more time to direct patient care. This collaboration is expected to improve diagnostic precision and

therapeutic decision-making, ultimately leading to better patient outcomes [38].

9.3. Sustainable Development and International Cooperation

The continued evolution of AI in medicine must address challenges such as data security, algorithmic

bias, and disparities in access to technology. Establishing clear ethical guidelines and regulatory policies

will be crucial in ensuring equitable AI deployment. Additionally, fostering global collaboration among

researchers, policymakers, and industry leaders will aid in standardizing AI integration and promoting

responsible innovation in healthcare [39].

9.4. Conclusion

AI has already begun revolutionizing healthcare, improving diagnostics, treatment planning, and patient

management. Future advancements in multimodal AI, federated learning, and generative AI are expected

to drive further progress. The synergy between AI and healthcare professionals, alongside sustainable AI

practices and international cooperation, will be key to unlocking AI’s full potential in medicine.

References

[1] M. Alloghani, D. Al-Jumeily, A. J. Aljaaf, M. Khalaf, and S. Y. Tan, “The application of artiﬁcial intelligence technology in

healthcare: A systematic review,” 2020.

[2] K. Moulaei, A. Yadegari, M. Baharestani, S. Farzanbakhsh, B. Sabet, and M. R. Afrash, “Generative artiﬁcial intelligence in

healthcare: A scoping review on beneﬁts, challenges and applications,” International Journal of Medical Informatics, vol. 188,

2024.

[3] E. G

omez-Gonz

alez, E. Gomez, J. M

arquez-Rivas, M. Guerrero-Claro, I. Fern

andez-Lizaranzu, M. I. Relimpio-L

opez, M. E.

Dorado, M. J. Mayorga-Buiza, G. Izquierdo-Ayuso, and L. Capit

an-Morales, “Artiﬁcial intelligence in medicine and healthcare:

a review and classiﬁcation of current and near-future applications and their ethical and social impact,” 2020.

[4] M. Nasr, . M. Islam, S. Shehata, F. Karray, and Y. Quintana, “Smart healthcare in the age of ai: Recent advances, challenges,

and future prospects,” 2021.

[5] B. S. Ingole, V. Ramineni, N. K. Pulipeta, M. J. Kathiriya, M. S. Krishnappa, and V. Jayaram, “The dual impact of artiﬁcial

intelligence in healthcare: Balancing advancements with ethical and operational challenges,” 2024.

[6] G. Litjens, T. Kooi, B. E. Bejnordi, A. A. A. Setio, and C. I. S

anchez, “A survey on deep learning in medical image analysis,”

Medical Image Analysis, vol. 42, no. 9, pp. 60–88, 2017.

[7] H. Greenspan, B. V. Ginneken, and R. M. Summers, “Guest editorial deep learning in medical imaging: Overview and future

promise of an exciting new technique,” IEEE Transactions on Medical Imaging, vol. 35, no. 5, pp. 1153–1159, 2016.

[8] B. Allison, X. Ye, and F. Janan, “Mixr: A standard architecture for medical image analysis in augmented and mixed reality,”

IEEE, 2020.

[9] V. Guarrasi, F. Aksu, C. M. Caruso, F. Di Feola, A. Rofena, F. Rufﬁni, and P. Soda, “A systematic review of intermediate

fusion in multimodal deep learning for biomedical applications,” 2024.

[10] K. He, C. Gan, Z. Li, I. Rekik, Z. Yin, W. Ji, Y. Gao, Q. Wang, J. Zhang, and D. Shen, “Transformers in medical image

analysis: A review,” 2022.

[11] Z. Yang, X. Zeng, Y. Zhao, and R. Chen, “Alphafold2 and its applications in the ﬁelds of biology and medicine,” Signal

Transduction and Targeted Therapy, vol. 8, no. 1, p. 115, 2023.

Vol. 01, No. 01, March 2025 Page 29

International Journal of Artiﬁcial Intelligence for Science AI for Medical Application Review

[12] X. Tang, H. Dai, E. Knight, F. Wu, Y. Li, T. Li, and M. Gerstein, “A survey of generative ai for de novo drug design: new

frontiers in molecule and protein generation,” Brieﬁngs in Bioinformatics, vol. 25, no. 4, p. bbae338, 2024.

[13] Q. Liao, Y. Zhang, Y. Chu, Y. Ding, Z. Liu, X. Zhao, Y. Wang, J. Wan, Y. Ding, P. Tiwari et al., “Application of artiﬁcial

intelligence in drug-target interactions prediction: A review,” npj Biomedical Inn ovations, vol. 2, no. 1, p. 1, 2025.

[14] K. B. Johnson, W.-Q. Wei, D. Weeraratne, M. E. Frisse, K. Misulis, K. Rhee, J. Zhao, and J. L. Snowdon, “Precision medicine,

ai, and the future of personalized health care,” Clinical and translational science, vol. 14, no. 1, pp. 86–93, 2021.

[15] A.-D. E. Parekh, O. A. Shaikh, S. Manan, M. Al Hasibuzzaman et al., “Artiﬁcial intelligence (ai) in personalized medicine:

Ai-generated personalized therapy regimens based on genetic and medical history,” Annals of Medicine and Surgery, vol. 85,

no. 11, pp. 5831–5833, 2023.

[16] B. Stuart, T. Danaher, R. Awdish, and L. Berry, “Finding hope and healing when cure is not possible,” in Mayo Clinic

Proceedings, vol. 94, no. 4. Elsevier, 2019, pp. 677–685 .

[17] N. Schopow, G. Osterhoff, and D. Baur, “Applications of the natural language processing tool chatgpt in clinical practice:

comparative study and augmented systematic review,” JMIR Medical Informatics, vol. 11, p. e48933, 2023.

[18] J. E. Knudsen, U. Ghaffar, R. Ma, and A. J. Hung, “Clinical applications of artiﬁcial intelligence in robotic surgery,” Journal

of robotic surgery, vol. 18, no. 1, p. 102, 2024.

[19] M. Iftikhar, M. Saqib, M. Zareen, and H. Mumtaz, “Artiﬁcial intelligence: revolutionizing robotic surgery,” Annals of Medicine

and Surgery, vol. 86, no. 9, pp. 5401–5409, 2024.

[20] P. Mascagni, D. Alapatt, L. Sestini, M. S. Altieri, A. Madani, Y. Watanabe, A. Alseidi, J. A. Redan, S. Alﬁeri, G. Costamagna

et al., “Computer vision in surgery: from potential to clinical value,” npj Digital M edicine, vol. 5, no. 1, p. 163, 2022.

[21] L. Yang and K. Etsuko, “Review on vision-based tracking in surgical navigation,” IET Cyber-Systems and Robotics, vol. 2,

no. 3, pp. 107–121, 2020.

[22] E. Siddig, H. F. Eltigani, and A. Ahmed, “The rise of ai: How artiﬁcial intelligence is revolutionizing infectious disease control.”

Annals of biomedical engineering, 2023.

[23] I. Andras, E. Mazzone, F. W. van Leeuwen, G. De Naeyer, M. N. van Oosterom, S. Beato, T. Buckle, S. O’Sullivan, P. J. van

Leeuwen, A. Beulens et al., “Artiﬁcial intelligence and robotics: a combination that is changing the operating room,” World

journal of urology, vol. 38, pp. 2359–2366, 2020.

[24] T. D. Lalitharatne, L. Costi, R. Hashem, I. Nisky, R. E. Jack, T. Nanayakkara, and F. Iida, “Face mediated human–robot

interaction for remote medical examination,” Scientiﬁc reports, vol. 12, no. 1, p. 12592, 2022.

[25] B. Fida, F. Cutolo, G. di Franco, M. Ferrari, and V. Ferrari, “Augmented reality in open surgery,” Updates in surgery, vol. 70,

no. 3, pp. 389–400, 2018.

[26] C. Y. Ko, B. L. Hall, A. J. Hart, M. E. Cohen, D. B. Hoyt et al., “The american college of surgeons national surgical quality

improvement program: achieving better and safer surgery,” The Joint Commission Journal on Quality and Patient Safety, vol. 41,

no. 5, pp. 199–AP1, 2015.

[27] A. Sarkar, P. Singh, and M. Varkey, “Healthcare artiﬁcial intelligence in india and ethical aspects,” in AI, consciousness and

the New Humanism: Fundamental reﬂections on minds and machines. Springer, 2024, pp. 107–150.

[28] E. Hossain, R. Rana, N. Higgins, J. Soar, P. D. Barua, A. R. Pisani, and K. Turner, “Natural language processing in electronic

health records in relation to healthcare decision-making: a systematic review,” Computers in biology and medicine, vol. 155,

p. 106649, 2023.

[29] S. A. Alowais, S. S. Alghamdi, N. Alsuhebany, T. Alqahtani, A. I. Alshaya, S. N. Almohareb, A. Aldairem, M. Alrashed,

K. Bin Saleh, H. A. Badreldin et al., “Revolutionizing healthcare: the role of artiﬁcial intelligence in clinical practice,” BMC

medical education, vol. 23, no. 1, p. 689, 2023.

[30] L. Yang, S. Lu, and L. Zhou, “The implications of artiﬁcial intelligence on infection prevention and control: Current progress

and future perspectives,” China CDC weekly, vol. 6, no. 35, p. 901, 2024.

[31] M. Chen and M. Decary, “Artiﬁcial intelligence in healthcare: An essential guide for health leaders,” in Healthcare management

forum, vol. 33, no. 1. Sage Publications Sage CA: Los Angeles, CA, 2020, pp. 10–18.

[32] S. Gerke, T. Minssen, and G. Cohen, “Ethical and legal challenges of artiﬁcial intelligence-driven healthcare,” in Artiﬁcial

intelligence in healthcare. Elsevier, 2020, pp. 295–336.

[33] S. Shajari, K. Kuruvinashetti, A. Komeili, and U. Sundararaj, “The emergence of ai-based wearable sensors for digital health

technology: a review,” Sensors, vol. 23, no. 23, p. 9498, 2023.

[34] F. Tsvetanov, “Integrating ai technologies into remote monitoring patient systems,” Engineering Proceedings, vol. 70, no. 1,

p. 54, 2024.

[35] N. Yadav, S. Pandey, A. Gupta, P. Dudani, S. Gupta, and K. Rangarajan, “Data privacy in healthcare: In the era of artiﬁcial

intelligence,” Indian Dermatology Online Journal, vol. 14, no. 6, pp. 788–792, 2023.

[36] D. Ueda, T. Kakinuma, S. Fujita, K. Kamagata, Y. Fushimi, R. Ito, Y. Matsui, T. Nozaki, T. Nakaura, N. Fujima et al., “Fairness

of artiﬁcial intelligence in healthcare: review and recommendations,” Japanese Journal of Radiology, vol. 42, no. 1, pp. 3–15,

2024.

[37] T. Tu, S. Azizi, D. Driess, M. Schaekermann, M. Amin, P.-C. Chang, A. Carroll, C. Lau, R. Tanno , I. Ktena et al., “Towards

generalist biomedical ai,” Nejm Ai, vol. 1, no. 3, p. AIoa2300138, 2024.

[38] A. M. K. Sherani, M. Khan, M. U. Qayyum, and H. K. Hussain, “Synergizing ai and healthcare: Pioneering advances in cancer

medicine for personalized treatment,” International Journal of Multidisciplinary Sciences and Arts, vol. 3, no. 2, pp. 270–277,

2024.

[39] S.-e. Sugawara, “The multistability of predictive technology in nuclear disasters,” Social Studies of Science, vol. 53, no. 4, pp.

495–521, 2023.

Vol. 01, No. 01, March 2025 Page 30